GENEVA (Reuters) - A World Trade Organization agreement allowing poor countries to import generic medicines came into force on Monday, WTO Director General Roberto Azevedo told Reuters, after the deal reached the required two-thirds support of WTO members.
The original 1995 WTO rules allowed governments to produce generic medicines for their domestic markets without the patent owners' consent. But that meant poorer countries without manufacturing capacity could not get those drugs.
In 2003, WTO members agreed to give such countries a temporary waiver, which effectively became a permanent part of the WTO rules on Monday.
(Reporting by Tom Miles; editing by Stephanie Nebehay)
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
